Own immune cells injected to fight diabetic kidney damage
NCT ID NCT06866158
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 29 times
Summary
This study tests whether a single injection of a patient's own immune cells (dendritic cells and lymphocytes) can reduce protein in the urine, a sign of kidney damage, in people with type 2 diabetes. Eighty adults with diabetic kidney disease will receive the injection and be monitored for four weeks. The goal is to see if this approach can control the disease and improve kidney health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE (DKD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gatot Soebroto Central Army Hospital
Jakarta Pusat, DKI Jakarta - Jakarta, 10410, Indonesia
Conditions
Explore the condition pages connected to this study.